Nexalin Technology, Inc. (NXL): Total Liabilities
$887.3K
As of 2025-12-31
$1.48M
As of 2026-06-30
-23.1%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $887.3K | +62.3% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $546.7K | +28.5% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $425.3K | -78.2% | 2025-09-23, Balance as of period end |
| 2022-12-31 | $1.95M | -19.8% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $2.44M | n/a | 2023-03-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $887.3K | +62.3% |
| Positron Corp (POSC) | 2025-12-31 | $2.56M | +4.0% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $969.8K | +80.1% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $7.33M | +17.0% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $18.68M | +92.0% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $1.26M | -13.8% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $3.00M | +11.7% |
| Yubo International Biotech Ltd (YBGJ) | 2025-12-31 | $2.79M | -42.2% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.49M | +4.6% |
Compare NXL, POSC, ITOC, GTHP side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗